Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 23
Filter
1.
Rev. méd. Chile ; 140(12): 1548-1553, dic. 2012. tab
Article in Spanish | LILACS | ID: lil-674026

ABSTRACT

Background: ConQoL questionnaire assesses health related quality of life among children with congenital heart diseases. It has a version for children aged 8 to 11 years and anotherfor children aged 12 to 16years. Aim: To validate ConQol questionnaire for Chilean children with a congenital heart disease. Material and Methods: Using a multicentric cross sectional design, 334 children from four hospitals (54% males), were surveyed. Among them 45% were aged 8 to 11 years and 55%, 12 to 16 years. The study involved three stages: cross cultural adjustment of the original questionnaire, pre-test study, and estimation of its psychometric properties. Content, construct and criterion validity and internal consistency with Cronbach's alpha, were assessed. Results: The version for children aged 8 to 11 years and comprised by three domains (symptoms, activity and relationships), obtained and α ≥ 0.60. In the questionnaire for children aged 12 to 16years, there is one more domain called coping, which obtained an α of 0.53, that was different to the other three domains that obtained an α > 0.70. The correlation between Health Quality of Life and Perception of Health Quality of Life was statistically significant for both groups. The association between Health Quality ofLife and health capability was only significant among children aged 12 to 16years (p < 0.01). Conclusions: The adapted ConQol questionnaire matched properly with the original one. The adapted questionnaire is valid and reliable to assess Health Quality ofLife among Chilean children with congenital heart diseases.


Subject(s)
Adolescent , Child , Female , Humans , Male , Heart Defects, Congenital/psychology , Quality of Life , Surveys and Questionnaires/standards , Chile , Cross-Sectional Studies , Psychometrics , Reproducibility of Results
2.
Rev. méd. Chile ; 134(9): 1135-1145, sept. 2006. ilus, tab
Article in Spanish, English | LILACS | ID: lil-438416

ABSTRACT

Background: Cardiac tumors are very uncommon at all ages. There are important clinical differences between children and adults in the behavior of these tumors. Aim: To compare the behavior of primary and secondary cardiac tumors, from fetal age to adults. Patients and Method: Multicentric retrospective analysis of 38 children and adults with cardiac tumors, evaluated with echocardiography between January 1995 and August 2001. Medical records, echocardiographic and radiological examinations, surgical protocols and pathologic examinations were reviewed. Follow-up was obtained through data on medical records or calling patients by telephone. Results: Tumors were diagnosed in 38 patients (13 children and 25 adults), from a total of 31.800 echocardiograms. In children the diagnosis was made by fetal, transthoracic or transesophageal echocardiography in 23.6 percent and 8 percent of cases, respectively. Eighty five percent were primary (10 benign and 1 malignant) and 15 percent, secondary tumors. Fifty four percent were rhabdomyomas and 75 percent regressed spontaneously. Seventy seven percent were symptomatic and 31 percent were treated with surgery. During a follow up of 44±35 months, 31 percent of patients died. In adults, 76 percent of tumors were diagnosed by transthoracic and 20 percent by transesophageal echocardiography. Seventy six percent were primary (18 benign and 1 malignant) and 24 percent secondary tumors. Fifty six percent were myxomas. Ninety two percent were symptomatic and 84 percent were treated surgically. Twenty percent of patients died in the early postoperative period. No adult patients had a follow-up. Conclusions: Rhabdomyomas were solely found in children. In adults, myxomas are the predominat cardiac tumors. Primary and metastasic malignant tumors are observed both in children and in adults.


Subject(s)
Adult , Aged , Aged, 80 and over , Child , Child, Preschool , Female , Humans , Infant , Infant, Newborn , Male , Middle Aged , Pregnancy , Heart Neoplasms , Rhabdomyoma , Chile/epidemiology , Echocardiography , Fetal Heart , Fibroma/epidemiology , Fibroma , Follow-Up Studies , Heart Neoplasms/epidemiology , Myxoma/epidemiology , Myxoma , Retrospective Studies , Rhabdomyoma/epidemiology , Ultrasonography, Prenatal
3.
Rev. chil. pediatr ; 76(4): 375-383, ago. 2005. ilus, tab, graf
Article in Spanish | LILACS | ID: lil-433004

ABSTRACT

Antecedentes: El reemplazo valvular mitral (RVM) y aórtico (RVA) es poco frecuente en pacientes pediátricos y las series publicadas reportan elevada morbi-mortalidad. Objetivo: Evaluar los resultados a mediano plazo en niños sometidos a RVM y RVA durante los últimos diez años, con el fin de determinar morbimortalidad y calidad de vida. Método: Análisis retrospectivo de 26 niños consecutivos (mediana de edad 5,6 años) sometidos a RVM y RVA, entre marzo 1992 y junio 2003. Diecisiete presentaban patología mitral y once aórtica. Resultados: Se realizaron 26 operaciones implantando 28 prótesis (26 mecánicas y 2 biológicas). Tres pacientes (12 por ciento) fallecieron durante el primer mes. La mediana de seguimiento fue de 6,2 años. Tres pacientes con RVM fallecieron alejadamente por causa no atribuible al reemplazo valvular con una sobrevida actuarial de 87 por ciento. Tres pacientes requirieron reoperación. Todos realizan actividades adecuadas a su edad, restringiéndose los deportes de contacto. Conclusión: Los resultados a mediano plazo del reemplazo valvular en niños con valvulopatía grave son satisfactorios.


Subject(s)
Male , Adolescent , Humans , Female , Infant , Child, Preschool , Child , Heart Valve Prosthesis , Heart Valve Prosthesis Implantation , Aortic Valve/surgery , Mitral Valve/surgery , Anticoagulants/therapeutic use , Bioprosthesis , Follow-Up Studies , Heart Valve Prosthesis Implantation/instrumentation , Heart Valve Prosthesis Implantation/mortality , Prosthesis Failure , Reoperation , Retrospective Studies , Survival Rate , Treatment Outcome
4.
Rev. méd. Chile ; 132(5): 549-555, mayo 2004. tab
Article in Spanish | LILACS | ID: lil-384412

ABSTRACT

Background : Streptococcus agalactiae or group B streptococcus, GBS, is the leading cause of neonatal and maternal infections and an opportunistic pathogen in adults with underlying disease. In the last decade, a dramatic increase in the resistance of this microorganism to erythromycin and clindamycin has been observed. Aim: To determine the serotype distribution and antimicrobial susceptibility of isolates of S agalactiae collected from infections and colonization and to assess the genetic mechanisms of macrolide and clindamycin resistance. Material and methods: A total of 100 GBS isolates were collected between 1998 and 2002, in Santiago, Chile. They were isolated from the amniotic fluid from patients with premature rupture of membranes (7 isolates), blood from neonatal sepsis (10 isolates), neonate colonizations (2 strains), skin and soft tissue infections (7 isolates), urinary tract infections (5 isolates), genital infections (3 isolates), articular fluid (one isolate), and 65 strains were recovered from vaginal colonization55. Results: Serotypes Ia, II and III were the predominant serotypes identified in our study, accounting for 90 (90 percent) of the strains. Five isolates belonged to serotypes Ib (5 percent) and two (2 percent) to serotype V respectively; no strains belonging to serotype IV were found. All strains were susceptible to penicillin G, ampicillin and cefotaxime, and four isolates (4 percent) were resistant to both erythromycin (MIC >64 µg/ml) and clindamycin (MIC >64 µg/ml). The strains had a constitutive macrolide-lincosamide-streptogramin (cMLSB) resistance phenotype and the erm(A) gene was present in the four isolates. Conclusions: Serotypes Ia, II and III were the predominant serotypes in this study. All strains were susceptible to penicillin G, ampicillin and cefotaxime, and four (4 percent) strains were resistant to both erythromycin and clindamycin. The cMLSB resistance phenotype, and the erm(A) gene was detected in resistant strains (Rev MÚd Chile 2004; 132: 549-55).


Subject(s)
Streptococcus agalactiae/isolation & purification , Streptococcus agalactiae , Ampicillin/pharmacology , Cefotaxime/pharmacology , Clindamycin/pharmacology , Erythromycin/pharmacokinetics , Penicillins/pharmacology , Drug Resistance, Microbial , Serotyping , Microbial Sensitivity Tests/methods , Tetracycline/pharmacology
5.
Rev. méd. Chile ; 132(5): 556-563, mayo 2004. ilus, tab
Article in Spanish | LILACS | ID: lil-384413

ABSTRACT

Background: Norwood procedure is used as the first stage in the palliative treatment of the hypoplastic heart syndrome and can be used, with some technical modifications, in other forms of univentricular heart with aortic stenosis or hypoplasia. These patients have a high mortality (50 percent), derived from the procedure itself and from their abnormal physiological status. Aim: To report our experience with the Norwood procedure. Patients and methods: Retrospective analysis of all patients subjected to the Norwood procedure between February 2000 and June 2003. Results: Thirteen patients (9 females, age range 5-60 days and median weight of 3.3 kg) were operated. Eight had hypoplastic heart syndrome and five had a single ventricle with aortic arch hypoplasia. The diagnosis was done in utero in eight patients. All technical variations, according to the disposition and anatomy of the great vessels, are described. Cardiac arrest with profound hypothermia was used in all and regional cerebral perfusion was used in nine. Three patients died in the perioperative period and three died in the follow up (two, four and 10 months after the procedure). Gleen and Fontan procedures were completed in five and one patients, respectively. Conclusions: Our results with the Norwood procedure are similar to other series. There is an important mortality in the immediate operative period and prior to the Glenn procedure (Rev MÚd Chile 2004; 132: 556-63).


Subject(s)
Humans , Male , Female , Infant, Newborn , Infant , Hypoplastic Left Heart Syndrome , Heart Defects, Congenital/surgery , Chile , Patient Selection
6.
Rev. méd. Chile ; 132(1): 26-32, ene. 2004. tab
Article in Spanish | LILACS | ID: lil-359175

ABSTRACT

Background: DiGeorge syndrome is characterized by developmental defects of the heart, parathyroid glands and thymus. Aim: To describe the clinical variability of DiGeorge syndrome and its relation with immunodeficiency. Patients and methods: A three years retrospective chart review from three hospitals of Santiago, Chile was conducted. We included patients with neonatal diagnosis of DiGeorge syndrome. Clinical and immuno-logic data were collected from their initial evaluation. Results: We found 9 patients with DiGeorge syndrome. All had dysmorphic facies, hypocalcemia and congenital heart disease. Three patients had hypoparathyroidism, 4 had interrupted aortic arch type B, 4 had tetralogy of Fallot and 1 had coarctation of aorta. Six patients had other malformations and associated diseases. FISH studies, performed in 8 patients, found the 22q11.2 microdeletion in all. Most patients had low CD3, CD4 and CD8 T cell counts, that ranged for CD3 T cells, between 256/mm3 and 3,664/mm3, for CD4 T cells, between 224/mm3 and 2,649/mm3, for CD8 T cells, between 26/mm3 and 942/mm3. Three patients had CD4 T cells counts <400/mm3 and one had a phytohemagglutinin stimulation index <10. Airway malformations and primary hypoparathyroidism were present in 3 out of 4 patients that died before 18 months compared with the surviving patients (p=0.048). Conclusions: We found variable clinical manifestations as well as CD3, CD4 and CD8 T cell counts in patients with DiGeorge syndrome. Airway malformations were associated with a higher mortality (Rev Méd Chile 2004; 132: 26-32).


Subject(s)
Humans , DiGeorge Syndrome/immunology , Chile , Chromosome Disorders
7.
Hematología (B. Aires) ; 7(3): 167-175, nov.-dic. 2003. tab, graf
Article in Spanish | LILACS | ID: lil-384959

ABSTRACT

Introducción: El sistema inmune no es capaz de reconocer los cambios en células transformadas por mutaciones en la leucemia linfática crónica de estirpe B (LLC-B). Su incubación con linfocitos autólogos no induce citotoxicidad. Puede deberse a la ausencia de linfocitos T citotóxicos o a la incapacidad de las células de LLC en expresar moléculas coestimulatorias (CD80, CD86), a pesar de tener expresión de HLA clase I y II. El ADN bacteriano y los ODNs que contienen motivos PyNTTrrGT, CpG y otros motivos, pueden activar a los monocitos, las células dendríticas y los linfocitos B. Aparte, algunos ODNs tienen efectos directos sobre las células LLC-B. Material y métodos: se incubaron células leucémicas provenientes de 20 pts. con LLC-B con 3 diferentes ODNs: a) IMT504, con motivos PyNTTrrGT b) 2006 con motivos CpG y c) ODN inactivo de control. Previo y posterior a la incubación se efectuaron determinaciones de CD80, CD86, CD40, MHC clase I y II, CD5, CD19 y CD20 por citometría de flujo. Además se determinó (por medio de la detección de fosfatidilserina por la unión ala Anexina V) la capacidad de inducir la apotosis de las células transformadas, y se estudió la morfología de las células en cultivo. Resultados: Se observó el aumento de la detección de fosfatidilserina por la unión ala Anexina V) la capacidad de inducir la apotosis de las células transformadas, y se estudió la morfología de las células en cultivo. Resultados: Se observó el aumento de la expresión de CD80, CD86 y CD40 en las células incubadas con IMT504 y 2006. Además las células LLC-B expresaron significativamente mayor cantidad de Anexina v. La morfología de las células en cultivo a largo plazo mostró las características de apoptosis. Los estudios efectuados con el ODN de control no mostraron ninguna de las características descritas. Conclusión: La incubación de ODN con motivos PyNTTTTGT (IMT504) y con motivos CpG (2006) induce en las células de LLC-B un fenotipo considerado de células presentadoras de antígenos, y además apoptosis. Perspectiva: En otros estudios preclínicos y clínicos los ODNs han demostrado muy baja toxicidad, lo que permitiria efectuar estudios de Fase I/II en LLC-B


Subject(s)
Leukemia, Lymphocytic, Chronic, B-Cell , Oligonucleotides
9.
Rev. chil. pediatr ; 72(6): 516-523, nov.-dic. 2001. ilus, tab
Article in Spanish | LILACS | ID: lil-313233

ABSTRACT

Objetivo: evaluar retrospectivamente el rendimiento del cierre del ductus arterioso persistente (DAP) con técnica transcatéter, utilizando espirales (coils) de Gianturco. Pacientes y Métodos: entre octubre de 1996 y septiembre de 2000, 22 pacientes de peso mayor de 10 kg (10,5 a 59), portadores de DAP de hasta 4 mm en su diámetro menor, fueron sometidos a esta técnica de cierre. Bajo sedación con midazolam y ketamina, se efectuó sondeo cardíaco vía arteria y vena femoral derechas, y aortografía. Por medio de un catéter multipropósito se avanzó espiral de Gianturco a través del ductus desde su extremo aórtico hasta posicionario en el DAP. Resultados: se logró cierre angiográfico ductal en 22 pacientes (100 por ciento), observándose mínima filtración residual por ecocardiograma con Doppier color en 3 pacientes (14 por ciento), consignándose ausencia de filtración a los 15 días en dos de ellos. Todos los pacientes fueron dados de alta a las 24 horas. Cuatro pacientes presentaron embolización del espiral, los que fueron recuperados durante el procedimiento. Conclusión: el cierre transcateterismo de DAP con espirales de Gianturco es una técnica segura y efectiva, contituyendo una muy buena alternativa al cierre quirúrgico, con el beneficio adicional de no requerir anestesia general ni toracotomía


Subject(s)
Humans , Male , Adolescent , Adult , Female , Infant , Child, Preschool , Cardiac Catheterization/instrumentation , Ductus Arteriosus, Patent , Embolization, Therapeutic/instrumentation , Aortography , Cardiac Catheterization/methods , Ductus Arteriosus, Patent , Embolization, Therapeutic/methods , Retrospective Studies
10.
Rev. méd. Chile ; 129(5): 515-21, mayo 2001. ilus, tab
Article in Spanish | LILACS | ID: lil-295253

ABSTRACT

Background: DiGeorge anomaly, velocardiofacial syndrome and conotruncal anomaly face syndrome are part of a group of congenital malformations of the chromosome 22q11 microdeletion syndrome, since they share certain phenotypic features as well as a common genetic abnormality. The malformations include mild facial dysmorphic features, conotruncal heart defects, thymic and parathyroid hypoplasia or aplasia and cleft palate. Aim: To describe the initial clinical presentation of children with clinical and molecular diagnosis of 22q11 microdeletion. Patients and methods: Ten children (seven male) with the phenotypic features of 22q11 microdeletion syndrome are reported. Microdeletion was detected in peripheral Iymphocytes by fluorescent in situ hybridisation (FISH) with the TUPLE-1 DNA probe. Results: Two children had abnormal karyotypes, one of them had a visible deletion and another child had an unbalanced translocation inherited from his mother who had a balanced translocation between chromosomes 14 and 22. Two of the 10 patients had an anterior laryngeal web, a malformation infrequently described in this syndrome. Five patients had the diagnosis of DiGeorge anomaly, had a more serious clinical presentation and a higher early mortality. Conclusions: The high frequency of the 22q11 microdeletion syndrome, estimated at 1:5.000 newborns, and its variable presentations requires a high level of awareness for its early diagnosis and appropriate management of associated complications


Subject(s)
Humans , Male , Female , Infant, Newborn , Infant , Child, Preschool , Chromosomes, Human, Pair 22/genetics , Chromosome Deletion , Chromosome Aberrations/genetics , Phenotype , In Situ Hybridization , DiGeorge Syndrome/diagnosis , DiGeorge Syndrome/etiology
11.
Rev. chil. pediatr ; 70(6): 457-63, dic. 1999. tab
Article in Spanish | LILACS | ID: lil-263507

ABSTRACT

En los últimos años se ha observado un progresivo aumento de publicaciones que describen alteraciones del ritmo cardíaco graves, e incluso muerte súbita, en pacientes pediátricos que reciben fármacos habituales de la terapéutica pediátrica. Entre los fármacos mencionados destacan cisaprida y otros de uso gastroenterológico, antibióticos macrólidos, antifúngicos, antihistamínicos y psicotrópicos. Estas complicaciones son poco frecuentes, ocurren en relación a sobredosis, uso combinado de ellos o en determinadas condiciones de mayor susceptibilidad de los pacientes. Estos fármacos pueden prolongar anormalmente el intervalo QT del electrocardiograma, lo que predispone a arritmias ventriculares graves y a muerte súbita. Se revisan algunos de estos fármacos, se describen los mecanismos a través de los cuales producen estas arritmias y se dan recomendaciones para su uso seguro en pediatría, especialmente en pacientes con mayor susceptibilidad, y así prevenir esta seria complicación de la farmacoterapia pediátrica


Subject(s)
Humans , Child , Death, Sudden/etiology , Long QT Syndrome/chemically induced , Anti-Arrhythmia Agents/adverse effects , Antifungal Agents/adverse effects , Antipsychotic Agents/adverse effects , Antidepressive Agents/adverse effects , Cisapride/adverse effects , Cytochrome P-450 Enzyme System/antagonists & inhibitors , Drug Combinations , Histamine H1 Antagonists/adverse effects , Psychotropic Drugs/adverse effects , Tachycardia, Ventricular/chemically induced
13.
Rev. chil. pediatr ; 61(4): 185-8, jul.-ago. 1990. tab
Article in Spanish | LILACS | ID: lil-90077

ABSTRACT

Se estudiaron 31 lactantes ingresados entre mayo y agosto de 1988 a una sala índice del Servicio de Pediatría, Hospital San Juan de Dios, Santiago de Chile, con diagnóstico de IRA baja, con el propósito de conocer la incidencia de la infección nosocomial respiratoria en la primera semana de hospitalización. En cada niño se realizó estudio virológico y bacteriológico seriado. En 13 de los 31 pacientes se detectó uno o más agentes virales nuevos en la segunda muestra (18 nuevos aislamientos en total), los que podrían haber sido adquiridos durante la hospitalización; los segundos virus fueron: Ad (n = 8), VRS (n = 5) y CMV (n = 5). No se detectaron cambios significativos de la flora bacteriana en el período estudiado


Subject(s)
Infant , Humans , Cross Infection/epidemiology , Respiratory Tract Infections/epidemiology , Acute Disease , Adenoviruses, Human/isolation & purification , Antigens, Viral/analysis , Cross Infection/etiology , Cytomegalovirus/isolation & purification , Incidence , Respiratory Syncytial Viruses/isolation & purification , Respiratory Tract Infections/etiology , Respirovirus/isolation & purification
SELECTION OF CITATIONS
SEARCH DETAIL